Velabs Therapeutics
Latest round
- Series B
Last raised
- Jun 2019
Total raised
- $3.4M
Investors
- 2
About Velabs Therapeutics
Founded in 2017 in Heidelberg, Germany, Velabs Therapeutics GmbH develops biotherapeutic solutions aimed at improving patient care.Velabs Therapeutics specializes in developing biotherapeutic products that address unmet medical needs across various therapeutic areas. Their offerings include monoclonal antibodies and protein-based therapeutics targeting specific diseases, particularly in oncology and autoimmune disorders. These products are intended for use by healthcare providers, including hospitals and specialty clinics, to enhance patient care.Revenue for Velabs Therapeutics is generated through direct sales of therapeutic products and strategic partnerships with healthcare organizations. The company engages in B2B transactions, supplying healthcare providers with biotherapeutics for advanced treatment options.Looking ahead, Velabs Therapeutics aims to launch new therapeutic products designed to address specific medical needs within the next two years.00 mn will support the development and potential market entry of these products. Additionally, the company plans to expand into markets in Asia and North America, targeting a broader client base by 2022, thereby increasing their global footprint.
Who invested in Velabs Therapeutics
2 investors across 1 round
See all investors in Velabs Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jun 11, 2019
Amount
$3.4M
Investors
Questions about Velabs Therapeutics
Who invested in Velabs Therapeutics?
Velabs Therapeutics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Velabs Therapeutics raised?
Velabs Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Velabs Therapeutics last raise money?
Velabs Therapeutics's most recent round on record is a Series B, in Jun 2019.
What does Velabs Therapeutics do?
Founded in 2017 in Heidelberg, Germany, Velabs Therapeutics GmbH develops biotherapeutic solutions aimed at improving patient care.
Where is Velabs Therapeutics headquartered?
Velabs Therapeutics is headquartered in Heidelberg, Germany.
Which VCs invest in companies like Velabs Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Velabs Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Velabs Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.